Australia’s first targeted treatment for the most common inherited heart disease is now reimbursed on the Pharmaceutical Benefits Scheme (PBS)
Australia’s first targeted treatment for the most common inherited heart disease is now reimbursed on the Pharmaceutical Benefits Scheme (PBS)
LIV on the hunt for new contributors Exciting news! Team LIV is looking for new contributors who have plenty to say about…
